These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Efficacy of immunologic monitoring after renal transplantation. Miller J; Lifton J; DeWolf WC; Stevens BJ; Wilcox C Transplant Proc; 1977 Mar; 9(1):59-64. PubMed ID: 325794 [No Abstract] [Full Text] [Related]
28. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants. Billen EV; Christiaans MH; van den Berg-Loonen EM Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037 [TBL] [Abstract][Full Text] [Related]
29. The impact of gender and age matching for long-term graft survival in living donor renal transplantation. Kwon OJ; Kwak JY; Kang CM Transplant Proc; 2005 Mar; 37(2):726-8. PubMed ID: 15848514 [TBL] [Abstract][Full Text] [Related]
30. Prediction of acute rejection before kidney transplantation treated with donor specific transfusion plus azathioprine. Aikawa A; Tashiro M; Arai K; Ohara T; Iwashita Y; Kimura I; Hirata K; Hasegawa A Transplant Proc; 1989 Feb; 21(1 Pt 2):1839-41. PubMed ID: 2523596 [No Abstract] [Full Text] [Related]
31. [HLA-compatibility testing in kidney transplantation--past, present and future]. van Rood JJ; Persijn GG; van Leeuwen A; Goulmy E; Lansbergen Q; Cohen B Chirurg; 1980 May; 51(5):257-62. PubMed ID: 6447582 [No Abstract] [Full Text] [Related]
32. Kidney transplantation in children: impact of young recipient age on graft survival. Lufft V; Tusch G; Offner G; Brunkhorst R Nephrol Dial Transplant; 2003 Oct; 18(10):2141-6. PubMed ID: 13679493 [TBL] [Abstract][Full Text] [Related]
33. Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. Hourmant M; Cesbron-Gautier A; Terasaki PI; Mizutani K; Moreau A; Meurette A; Dantal J; Giral M; Blancho G; Cantarovich D; Karam G; Follea G; Soulillou JP; Bignon JD J Am Soc Nephrol; 2005 Sep; 16(9):2804-12. PubMed ID: 16014742 [TBL] [Abstract][Full Text] [Related]
34. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340 [TBL] [Abstract][Full Text] [Related]
35. [The significance of mixed lymphocyte culture and mitogen-stimulated culture for kidney transplantation (author's transl)]. Hajek-Rosenmayr A; Wolf A Wien Klin Wochenschr; 1981 Jul; 93(14):457-60. PubMed ID: 6455859 [TBL] [Abstract][Full Text] [Related]
36. Multifactorial analysis of factors influencing graft survival in recipients of living related renal allografts. Green WF; Niblack GD; Johnson HK; Richie RE; Tallent MB; MacDonnell R; Turner B; Harbison P; Ganaway S Transplant Proc; 1982 Jun; 14(2):282-6. PubMed ID: 6214057 [No Abstract] [Full Text] [Related]
38. The role of the HLA-D (D and DR) locus in the rejection of allografts. Dausset J; Fauchet R; Suet C; Busson M; Schmid M; Hors J Adv Nephrol Necker Hosp; 1980; 9():223-35. PubMed ID: 6773313 [No Abstract] [Full Text] [Related]
39. The influence of histocompatibility on graft and patient survival in primary cadaver kidney transplantation. Storm B; Lindholm A Proc Eur Dial Transplant Assoc; 1972; 9():466-74. PubMed ID: 4589765 [No Abstract] [Full Text] [Related]
40. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation. Ji S; Liu M; Chen J; Yin L; Sha G; Chen H; Liu Z; Li L Clin Transplant; 2004 Oct; 18(5):536-40. PubMed ID: 15344956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]